RT Journal Article
T1 Addressing the medicines access challenge through balance, evidence, collaboration and transparency: key take-away lessons of the 4th PPRI Conference.
A1 Vogler, Sabine
A1 Zimmermann, Nina
A1 Babar, Zaheer-Ud-Din
A1 Busse, Reinhard
A1 Espin-Balbino, Jaime
A1 Mantel-Teeuwisse, Aukje K
A1 Panteli, Dimitra
A1 Suleman, Fatima
A1 Wirtz, Veronika J
K1 Access to medicines
K1 Affordability
K1 Collaboration
K1 Debate
K1 Medicine prices
K1 Policy options
K1 Pricing policies
K1 Reimbursement
AB The 4th PPRI Conference, held in Vienna in October 2019, addressed issues related to equitable and affordable access to medicines. A multi-stakeholder audience from around the globe discussed solutions and best practice models for current challenges such as high-priced medicines, limitations of current pricing and reimbursement policies and tight budgets for health technologies. A multi-faceted approach (so-called balance, evidence, collaboration and transparency/BECT strategy) was also discussed. This includes an improved balance of different interests and policy areas, generation of relevant evidence, collaboration between countries and stakeholders, and transparency, and was considered as the most promising pathway for the future.
PB BioMed Central
SN 2052-3211
YR 2021
FD 2021-01-25
LK http://hdl.handle.net/10668/17038
UL http://hdl.handle.net/10668/17038
LA en
NO Vogler S, Zimmermann N, Babar ZU, Busse R, Espin J, Mantel-Teeuwisse AK, et al. Addressing the medicines access challenge through balance, evidence, collaboration and transparency: key take-away lessons of the 4th PPRI Conference. J Pharm Policy Pract. 2021 Jan 25;14(1):18.
DS RISalud
RD Apr 6, 2025